Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors vs. other agents were tied to a slower eGFR decline for adults with ADPKD and type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback